Abstract P6-06-07: Gene expression changes in the epithelium and stroma of invasive ductal carcinoma and ductal carcinomain situ: A meta-analysis

Author(s):  
Andre Dempsey ◽  
Christina Yau ◽  
Olivier Harismendy ◽  
Jonah Donnenfield ◽  
Amrita Basu ◽  
...  
2008 ◽  
Vol 95 (5) ◽  
pp. 547-554 ◽  
Author(s):  
B. Ansari ◽  
S. A. Ogston ◽  
C. A. Purdie ◽  
D. J. Adamson ◽  
D. C. Brown ◽  
...  

2013 ◽  
Vol 2013 ◽  
pp. 1-7 ◽  
Author(s):  
Anita Bane

Ductal carcinomain situis a proliferation of malignant epithelial cells confined to the ductolobular system of the breast. It is considered a pre-cursor lesion for invasive breast cancer and when identified patients are treated with some combination of surgery, +/− radiation therapy, and +/adjuvant tamoxifen. However, no good biomarkers exist that can predict with accuracy those cases of DCIS destined to progress to invasive disease or once treated those patients that are likely to suffer a recurrence; thus, in the era of screening mammography it seems likely that many patients with DCIS are overtreated. This paper details the parameters that should be included in a pathology report for a case of DClS with some explanations as to their importance for good clinical decision making.


2019 ◽  
Author(s):  
Shikha Roy ◽  
Rakesh Kumar ◽  
Vaibhav Mittal ◽  
Dinesh Gupta

AbstractEarly detection of breast cancer and its correct stage determination are important for prognosis and rendering appropriate personalized clinical treatment to breast cancer patients. However, despite considerable efforts and progress, there is a need to identify the specific genomic factors responsible for, or accompanying Invasive Ductal Carcinoma (IDC) progression stages, which can aid the determination of the correct cancer stages. We have developed two-class machine-learning classification models to differentiate the early and late stages of invasive ductal carcinoma. The prediction models are trained with RNA-seq gene expression profiles representing different IDC stages of 610 patients, obtained from The Cancer Genome Atlas (TCGA). Different supervised learning algorithms were trained and evaluated with an enriched model learning, facilitated by different feature selection methods. We also developed a machine-learning classifier trained on the same datasets with training sets reduced data corresponding to IDC driver genes. Based on these two classifiers, we have developed a web-server Duct-BRCA-CSP to predict early stage from late stages of IDC based on input RNA-seq gene expression profiles. The analysis conducted by us also enables deeper insights into the stage-dependent molecular events accompanying breast ductal carcinoma progression. The server is publicly available at http://bioinfo.icgeb.res.in/duct-BRCA-CSP.


Sign in / Sign up

Export Citation Format

Share Document